London Global Cancer Week (LGCW) shared on LinkedIn:

“Global surveillance of trends in population-based cancer survival – CONCORD-4

Join the London School of Hygiene and Tropical Medicine during London Global Cancer Week 2026 for a seminar presenting results from the fourth cycle of the CONCORD program.

CONCORD is an ambitious global public health program for the long-term surveillance of population-based cancer survival.

The latest cycle, CONCORD-4, has analyzed anonymized individual data on over 83 million adults diagnosed with one of 22 cancers during 1990–2022, accounting for 86–90% of the global cancer burden, and over 650,000 children diagnosed with any cancer.

Drawing on data from 383 population-based cancer registries in 75 countries worldwide, CONCORD-4 offers the largest available set of directly observed, real-world evidence on cancer survival in the world.